Finance
Argos Therapeutics awarded $21 million contract to develop HIV immunotherapy candidates
Published in AIDS Weekly, November 27th, 2006
Argos is developing personalized, RNA-loaded dendritic cell immunotherapy products designed to train the patient's immune system to recognize, target, and destroy unique features of their disease.
"This substantial NIH award provides important validation of Argos' pioneering approach to personalized immunotherapy, which may have strong applications not only for HIV, but also for cancer and other infectious diseases," commented Charles Nicolette, VP of Research and Development at Argos and Principle...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2006-11-27)
More Articles from AIDS Weekly
- HIV/AIDS Research
AIDS-related virus tricks cells to become tumors - HIV/AIDS Research
Researchers report significant findings in first clinical test of a new gene therapy for HIV/AIDS - HIV/AIDS Cancer
New HIV/AIDS cancer research from Abramson Family Cancer Research Institute, Department of Microbiology outlined - HIV/AIDS Cancer
Studies from University of Cape Town, Department of Medicine yield new information about HIV/AIDS cancer - HIV/AIDS Clinical Trial
Scientists at General Hospital target HIV/AIDS clinical trial - HIV/AIDS Co-Infection Genetics
New HIV/AIDS co-infection genetics research reported from Sungkyunkwan University, Department of Dermatology - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
